Benign Prostatic Hyperplasia

Marijuana Tied to Increased Risk for LUTS Medications in BPH

Publish Date May 6, 2019

Marijuana use also linked to worse overall semen parameters due to induction of oxidative stress

BPH Meds Found to Delay Prostate Cancer Diagnosis

Publish Date May 8, 2019

Men treated with 5-alpha reductase inhibitors were diagnosed with prostate cancer 2 years later than men not using these drugs.

Water Vapor Therapy for BPH Shows Good Short-Term Efficacy

Publish Date May 4, 2019

By 3 and 6 months, flow rate, post void residual, IPSS, quality of life, and prostate volume improved in patients treated with the Rezum system, which uses convective heating to ablate prostate tissue.

Aquablation Effective for BPH Despite Large Prostates

Publish Date May 3, 2019

Men with larger vs smaller prostate gland sizes treated with Aquablation experienced similar improvement in International Prostate Symptom Score.

Risk for T2DM Increased With Use of 5α-Reductase Inhibitors

Publish Date April 19, 2019

Increased risk seen among men using dutasteride, finasteride for benign prostatic hyperplasia

BPH Prostatic Artery Embolization Facilitated With MR Angiography

Publish Date March 12, 2019

Improved visualization of prostatic arteries shortens procedure time and decreases radiation exposure, new findings suggest.

Aquablation, TURP Outcomes Similar at 1 Year

Publish Date January 23, 2019

Randomized trial reveals no significant difference between Aquablation and TURP in improvements in lower urinary tract symptoms, peak urinary flow, and post-void residual volume.

Seminal Vesicle Problems May Be a PAE Complication

Publish Date December 27, 2018

Seminal vesicle abnormalities may beamong the complications of prostaticartery embolization (PAE), according toa new report published in BMC Urology. In a review of 139 patients whounderwent PAE for benign prostatehyperplasia,Jin Long Zhang, MD, ofNan Kai University in Tianjin, China, andcolleagues identified 9 (6.5%) who hadseminal vesicle abnormalities detectedby magnetic resonance imaging.  Theabnormalities included subacute hemorrhagein…

Desmopressin Effectively Treats Nocturia in BPH

Publish Date December 11, 2018

Nocturia improved 43% in patients receiving oral desmopressin alone and 64.3% in those receiving desmopressin and an alpha-blocker.

Most Transient SUI After HoLEP Resolves Within 6 Weeks

Publish Date August 30, 2018

Of patients who had transient stress urinary incontinence after holmium laser enucleation of the prostate, 88.6% experienced resolution of the incontinence within 6 weeks after the procedure.